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ABSTRACT 
Recombinant measles viruses are currently tested in clinical trials as oncolytic agent to be applied in cancer 
therapy. Contrary to their use as vaccine where 10
3 infectious virus particles per dose are needed, for cancer 
therapy 10
9 virus particles should be provided per dose. This leads to other challenges for the production 
process  when compared to vaccine production. This study presents measles virus stability with regard to 
conditions during production and storage of the virus. Relevant process parameters such as temperature (4-
37°C), pH (pH 4-11), conductivity (1.5 to 137.5 mS cm
-1) and oxygen partial pressure were analyzed. The 
infectivity of measles virus particles decreased highly at 37 and 32°C, while at 22 and 4°C it remained stable 
for several hours or even days, respectively. The thermal inactivation reactions followed first order kinetics 
and the thermodynamic parameters enthalpy and entropy were estimated. Towards changes in pH measles 
virus particles  were very sensitive,  while  no inactivation  could be observed  with varying conductivity. 
Measles virus incubation at an oxygen partial pressure of 100% did not lead to any loss of infectivity. The 
results show which parameters should be considered and controlled strongly in the production process to 
further raise measles virus yields for the high amount needed in cancer therapy approaches. 
 
Keywords: Measles Virus, Virus Stability, Virus Inactivation, Oncolytic Agent 
1. INTRODUCTION 
As  a  member  of  the  order  Mononegavirales  (family: 
Paramyxoviridae), Measles Virus (MV) is an RNA virus 
with a single stranded genome in negative-sense orientation. 
The  genome  is  wrapped  in  a  Ribonucleoprotein  (RNP) 
complex and enveloped by a lipid layer containing the viral 
glycoproteins  hemagglutinin  and  fusion  protein 
(Navaratnarajah et al., 2009). The virus particles have a size 
of 120-270 nm. MV is the causative agent of the disease 
measles, which is highly infectious and characterized by 
the  so  called  Koplik  spots,  high  fever  and  a  weakened 
immune system. Although the course of disease is often 
relatively  mild,  life-threatening  complications  such  as 
Subacute Sclerosing Panencephalitis (SSPE) appear with 
relative  low  frequency,  but  regularly  (Sabella,  2010). 
These complications can be prevented by vaccination 
with  attenuated  MV  vaccine  strains  which  have  been Weiss, K. et al. / American Journal of Biochemistry and Biotechnology 9 (3): 243-254, 2013 
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used in several millions of doses and have revealed an 
excellent safety profile.  
MV induces a Cytophatic Effect (CPE), i.e., cell-
to-cell  fusion  and  the  formation  of  multi-nucleated 
giant  cells,  ultimately  leading  to  induction  of 
apoptosis and killing of infected cells. Current studies 
in cancer therapy try to take benefit of this inherent 
cytotoxicity,  as  derivatives of  an  MV  vaccine  strain 
are currently tested in clinical trials for cancer therapy 
(Msaouel  et  al.,  2012).  The  ability  of  MV  to  kill 
cancer  cells  has  been  correlated  to  cell  entry  of 
attenuated MV via CD46; this receptor is frequently 
over-expressed on tumor cells (Anderson et al., 2004). 
Preclinical,  unmodified  and  recombinant  MV  strains 
have revealed oncolytic potency in numerous models 
including xenograft tumor models of human lymphoma 
(Grote et al., 2001), ovarian cancer (Peng et al., 2002), 
or prostate cancer (Msaouel et al., 2009). 
The  infectivity  of  MV  particles  is  the  basic 
requirement  for  the  success  of  oncolytic  virotherapy. 
Moreover,  the  amount  of  virus  particles  for  one 
therapeutic dose is up to 3 to 6 log10 units higher than 
those traditionally used for vaccination (Msaouel et al., 
2012; Russel et al., 2010). For these reasons, stability 
studies of MV under production conditions (especially 
medium,  oxygen  saturation,  ion  strength,  pH  and 
temperature)  are  important  to  retain  the  infectivity 
during upstream and downstream processing. This will 
be  essential  for  generation  of  the  required  doses  of 
infectious virus particles.  
Virus  inactivation  in  general  was  reported  to 
proceed similar to cell dying (Bauer and Henle, 1979; 
Johnson,  1974)  or  protein  and  enzyme  inactivation 
(Weemaes et al., 1997; 1998). All reports about MV 
stability in general have been published decades ago. 
Temperature  (Black,  1959;  Boriskin  et  al.,  1988; 
Musser  et al., 1960;  Rapp et  al., 1965), pH  (Black, 
1959;  Musser  et  al.,  1960)  and  salt  concentrations 
(Boriskin  et  al.,  1988;  Rapp  et  al.,  1965)  were  the 
most important factors analyzed, then. Recently, some 
work has focused on stability studies for MV vaccines 
after production and purification (Burger et al., 2008; 
Ohtake et al., 2010). While these virus particles are 
stabilized  with  different  agents  or  are  even 
lyophilized, this stability studies are not representative 
for  measles  virus  particles  under  production 
conditions. The key parameters for MV production for 
the  use  in  cancer  therapy  were  already  discussed  in  a 
previous review (Weiss et al., 2012). 
The  current  study  aims  to  target  MV  stability  of 
MV-batches  for  high-dose  applications  such  as 
virotherapy. For process parameters during production 
and  purification  the  presented  data  involve 
determination  of  temperature  inactivation  constants, 
analysis of the impact of pH, pO2, or certain salts. The 
determined  parameters  may  serve  as  a  basis  for 
optimizing  MV  production  and  purification  in  future 
applications  such  as  oncolytic  virotherapy  requiring 
comparatively high doses of infectious virus. 
2. MATERIALS AND METHODS 
2.1. Cells and Virus 
Infectious  recombinant  MV  particles  of  the  strain 
MVvac2  GFP  (P)  were  rescued  and  propagated  as 
described  previously  (Devaux  et  al.,  2007).  MV  was 
propagated  in  Vero  cells  (#  CCL-81,  ATCC)  under 
standard  culture  conditions.  Titers  were  determined 
according to (Karber, 1931; Reed and Muench, 1938). 
Cells  were  adapted  to  grow  in  serum  free  VPSFM 
medium (Gibco, Invitrogen) supplemented with 4 mM 
glutamine (PAA, Germany) over 5 passages and were 
expanded in T flasks at 37°C and 5% CO2, without any 
substituents  of  animal  origin.  Infections  were 
performed at a cell density of 50.000 cells cm
-2 with an 
MOI  of  0.02.  Measles  virus  suspensions  were  collected 
from  the  supernatant  after  centrifugation  (5  min,  300  g 
(Megafuge 1.0R, Thermo Scientific)). 
2.2. Temperature Stability Studies  
MV  suspension  were  incubated  at  4,  22,  32,  or 
37°C in the dark for the indicated time. After exposure 
at  4°C,  residual  virus  titers  were  always  determined 
immediately after sampling. After exposure at 22°C, 
32°C or 37°C samples were first frozen at-20°C in a 
radiator  block  to  immediately  stop  particle  decay 
before titrating residual titers. 
2.3. pH Stability Studies 
MV  particle  suspensions  were  supplemented  with 
appropriate volumes of 1 M NaOH or 1 M HCl to adjust 
the pH to the desired range. The virus solutions at pH 5, 6, 
7,  8,  9  and  10  were  titrated  according  to  the  TCID50 
method immediately after adjustment of pH and after 3 h 
incubation (at 4°C, in the dark), respectively. 
2.4. Salt Stability Studies 
MV suspensions were incubated with different salt 
solution at different concentrations. MgSO4 and NaCl 
solutions  at  1.5  M,  1  M,  0.5 M,  0.25  M  and  0.1  M 
were analyzed. For this purpose, appropriate volumes Weiss, K. et al. / American Journal of Biochemistry and Biotechnology 9 (3): 243-254, 2013 
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of  3  M  stock  solution  of  each  salt  were  given  to 
different aliquots of same virus suspensions to adjust 
salt  concentrations.  TCID50  titration  of  residual 
infectivity  was  done  immediately  after  salt 
supplementation  and  after  3  h  of  incubation. 
Conductivity  measurements  of  adjusted  suspensions 
were  performed  using  the  SevenGoDuoPro  device 
from Mettler Toledo. 
2.5. pO2 Stability Studies 
For the analysis of pO2 stability, MV suspensions were 
diluted  in  ice  cold  phosphate  buffer  saline  at  pH  7.2. 
Conditions  were  chosen  as  currently  tested  for  measles 
virus production (manuscript in preparation), using impeller 
stirrer in 1 L Stirred Tank Reactor (STR). 
3. RESULTS 
3.1. Measles Virus Thermal Inactivation 
To  investigate  the  MV  inactivation  rates  at 
different  temperatures,  measles  virus  suspensions 
were incubated at 37°C, 32°C (potential temperatures 
for  production),  22°C  (room  temperature),  or  4°C 
(storing temperature) and virus titer were determined 
after defined time spans. 
Figure 1 shows an increase of MV inactivation rates 
with increasing temperature. At 37°C and 32°C MV 
half-life were one and two hours respectively. When 
starting  with  a  titer of  6.3´10
5 TCID50/mL,  the  MV 
titer was below the limit of detection (10
2 TCID50/mL) 
after an incubation of 23 h at 37°C. At 22°C and 4°C, 
MV  was  more  stable  indicated  by  higher  half-life 
times (18 h and 5 d, respectively). 
In  Fig.  1  MV  inactivation  is  displayed 
semilogarithmic. An exponential regression was fitted to 
the data sets. The exponent of the respective regression 
lines gives the inactivation rate constant k. According to 
Arrhenius (Equation 1) the estimated k-values (lnk) against 
temperature (T
-1) resulted in a linear correlation (Fig. 2), 
where  the  slope  represents  the  term  EA  R
-1.  Taking 
Equation 2-4 the thermodynamic parameters enthalpy and 
entropy can be estimated (Johnson, 1974): 
 
A E
R T k A e × = ×   (1) 
 
Where: 
A  = The pre-exponential factor (h
-1) 
EA = The activation energy (kJ mol
-1) 
R  = The universal gas constant (kJ mol
-1 K
-1) 
T  = The temperature (K) 
G
B R T k T
k e
h
-D
× ×
= ×   (2) 
 
Eyring Equation, where: 
kB  = The Boltzmann constant (kJ K
-1) 
h  = The Planck’s constant (J s) 
∆G  = Gibbs energy (kJ mol
-1) 
 
A  H=E -R.T   (3) 
 
∆H is the enthalpy of activation (kJ mol
-1): 
 
1 S ( H G) T
- D = D -D ×   (4) 
 
∆S is the entropy of activation (kJ mol
-1 K
-1). 
The  estimated  thermodynamic  parameters  for  MV 
inactivation are presented in Table 1. The enthalpy for 
measlesvirus  inactivation  was  104 kJ mol
-1  (25  kcal 
mol
-1) and the entropy had a value of 0.08 kJ mol
-1 (0.02 
kcal mol
-1). 
3.2. Measles Virus pH Stability 
To estimate MV stability at various pH values, MV 
titers were determined at pH values between 4 and 11 
(Fig. 3). 
Directly  after  pH  adjustment,  the  MV  titer 
decreased below the limit of detection at pH 4 and pH 
11.  Therefore  MV  was  referred  to  be  completely 
inactivatedunder  these  conditions.  In  the  acid  pH 
range no infectious MV particles were found (pH 5) 
immediately after adjustment or a decrease of approx. 
2 orders of magnitude appeared (pH 6). In the basic 
pH range, directly after pH adjustment to pH 8, 9, or 
10,  MV  titers  decreased  by  approx.  one  order  of 
magnitude (1.1 to 1.6 log10 units). After 3h incubation 
time at acidic and basic pH MV titers were close to 
the detection limit in all approaches. 
The highest titer was estimated at pH 7. Interestingly, 
only small changes in pH from 7.2 to 7.0 resulted in a 
titer  decrease  of  one  order  of  magnitude  after  3h  of 
incubation, highlighting the sensitivity of MV particles 
against pH changes. 
3.3. Measles  Virus  Stability  at  Different  Salt 
Concentrations 
To estimate whether MV inactivation at various pH 
values away from neutral pH was due to increased salt 
concentrations, MV infectivity was analyzed at different 
salt  concentrations  and  conductivities.Weiss, K. et al. / American Journal of Biochemistry and Biotechnology 9 (3): 243-254, 2013 
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Fig. 1. Thermal inactivation of MV at 37°C, 32°C, 22°C and 4°C. Incubation studies were performed in triplicate, except for the 
temperature at 22°C. The virus titers are given as relative values divided by virus titer at time point zero of incubation. Lines 
represent exponential regression of respective data sets. Error bars indicate standard deviation. Weiss, K. et al. / American Journal of Biochemistry and Biotechnology 9 (3): 243-254, 2013 
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Fig. 2.  Arrhenius plot for measles virus thermal inactivation. Values for inactivation constant k were estimated by exponential 
regression of data sets from Fig. 1. 
 
 
 
Fig. 3. Inactivation of MV at different pH. For pH adjustment of MV suspensions, respective volumes of 1 M NaOH and 1 M 
HCl were added. Virus titers were determined directly after pH adjustment (black bars) or after 3 h incubation in the 
dark at 4°C (hatched bars). Weiss, K. et al. / American Journal of Biochemistry and Biotechnology 9 (3): 243-254, 2013 
 
249  Science Publications
 
AJBB 
 
 
Fig. 4. Oxygen stability of MV particles. Measles virus suspension was stirred in an STR at 70 rpm, pH 7.2, 0.1% (w/v) Pluronic 
F68 and 100% pO2; samples were taken at the indicated time points and subsequently titrated. The horizontal line at 1x10
4 
TCID50/mL is displayed for easier comparability of different values. 
 
Table  1. Estimated thermodynamic coefficients for measles virus thermal inactivation 
 H/kJ mol
-1   S/kJ mol
-1 K
-1   G/kJ mol
-1 
104  0.08  78 
 H/kcal mol
-1   S/kcal mol
-1 K
-1   G/kcal mol
-1 
25  0.02  19 
 
Table 2. Measles virus stability at different conductivities in diluted water and in NaCl and MgSO4 salt solutions 
    Log10 TCID50 mL
-1 
    ------------------------------------------------------------------------------ 
Sample name  Conductivity/mS cm
-1  Directly  After 3 h incubation 
Reference  013.28  6.10±0.17  6.47±0.23 
1.5M NaCl  137.50  6.19±0.42  6.60±0.44 
1M NaCl  094.30  6.21±0.15  6.31±0.55 
0.5M NaCl  054.70  6.07±0.06  6.46±0.53 
0.25M NaCl  037.80  5.92±0.30  6.39±0.69 
0.1M NaCl  023.99  5.83±0.11  6.66±0.43 
1.5M MgSO4  059.80  5.96±0.47  6.05±0.27 
1M MgSO4  052.90  6.13±0.43  6.62±0.35 
0.5M MgSO4  040.10  6.18±0.35  6.26±0.28 
0.25M MgSO4  032.10  6.57±0.23  6.18±0.54 
0.1M MgSO4  030.42  6.98±0.43  6.06±0.11 
Dilution factor (aquadest): 
2  006.71  6.37±0.26  6.12±0.51 
5  002.78  6.39±0.19  6.01±0.19 
10  001.49  6.15±0.13  5.77±.0.25Weiss, K. et al. / American Journal of Biochemistry and Biotechnology 9 (3): 243-254, 2013 
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  In  Table  2,  virus  titers  determined  at  different 
conductivities  and  salt  concentrations  are  displayed. 
Neither measles virus suspensions with NaCl, or MgSO4 
at 0.1 to 1.5 M, respectively, nor up to 10-fold dilutions 
with  distilled  water  resulted  in  significant  virus  titer 
decrease. Therefore, measles virus was observed to be 
very  stable  at  conductivities  between  1.5  to 137.5  mS 
cm
-1. Thus, a decrease of virus titer under different pH 
conditions  can  be  addressed  to  different  proton 
concentrations, not salt ions or conductivities. 
3.4. Measles Virus Oxygen Stability 
As  MV  is  produced  by  an  aerobically  host  cell, 
oxygen supply and sensitivity might play an important 
role for MV production. For this reason an exemplary 
analysis  was  done  to  estimate  MV  stability  under 
production  conditions.  Measles  virus  suspension  was 
stirred in STR at pH 7.2, 70 rpm, 8°C and 100% pO2 Fig. 4. 
Within 6 h, the virus titer did not vary to a significant 
level, so no inactivation has been observed due to high 
oxygen  partial  pressure.  Under  the  above  described 
conditions, oxygen concentration according to MV particles 
inactivation is not a critical factor for MV production. 
4. DISCUSSION 
For the application of measles virus in cancer therapy 
up  to  1,000,000  more  infectious  virus  particles  are 
needed  compared  to  vaccination  (Russel  et  al.,  2010). 
For this reason, first, an effective oncolytic measles virus 
production process should be established or the measles 
virus  has  to  be  highly  concentrated  with  preserved 
infectivity  to  get  these  high  titers.  Second,  since  a 
successful therapy will be dependent on the infectivity of 
the virus particles, measles virus stability is an important 
issue  and  has  to  be  integrated  into  MV  production 
considerations. In this study stability studies of infectious 
MV  suspensions  in  serum  free  medium  are  presented 
aiming  to  analyze  the  impact  of  conditions  like  pH  or 
temperature that play an important role during production 
of MV in upstream and downstream processing. Finally, 
critical  parameters  were  identified  to  further  raise  MV 
yields for the relative high amount needed e.g., for cancer 
therapy approaches (Russel et al., 2010).  
The  parameter  temperature  is  a  very  important 
factor,  as  temperatures  around  30°C  are  minimally 
required for the host cell maintenance metabolism and 
even  for  virus  production.  Contrary  MV  (Edmonston 
strain) has been reported to be very sensitive towards 
temperatures  above  30°C,  (Black,  1959;  Kohn  and 
Yassky, 1962; Musser et al., 1960; Rapp et al., 1965). 
A half-life of two hours was determined at 37°C for the 
Edmonston strain, according to about 100 % loss within 
4 h (Black, 1959), while a decrease in virus titer of 90 % 
within 16 h was reported by (Kohn and Yassky, 1962) 
and within 13 h by (Musser et al., 1960). The AIK-C 
MV strain at 28°C incubation was completely inactivated 
within 3 days (a loss of over 7 orders of magnitudes) and 
at 4°C the virus titer decreased about 2 log10 units within 
10 days and remained after that stable for another 2 days 
(Trabelsi  et  al.,  2012).  The  Edmonston  strain  lost  its 
infectivity at 23°C with a rate of approx. one order of 
magnitudes in 24 h (Black, 1959). In accordance with 
the data presented here, inactivation at 37°C or 32°C 
occurs  with  a  half-life  of  just  1  or 2  h,  respectively, 
where  an  inactivation  at  room  temperature  or  at  4°C 
was significantly slower (Fig. 1). 
The medium of the MV suspension seems to be an 
important  factor  for  MV  stability  at  different 
temperatures.  The  present  studies  were  done  in  serum 
free  VPSFM,  as  this  medium  is  suitable  for  MV 
production  under  serum  free  conditions  (own 
unpublished data). As already mentioned above, the half-
life  determined  in  the  current  set-up  were  quite 
comparable  to  those  reported  in  Eagle’s  medium 
supplemented with 10% calf serum (Black, 1959), where 
a  half-life  of  two  hours  was  determined  at  37°C.  In 
medium 199 without serum, a drop of infectivity of 2.4 
log10 units has been demonstrated after 7 h incubation at 
25°C. At 37°C no virus inactivation could be observed 
(3.2 +/-0.2 log10TCID50 mL
-1) but after 24 h a drop of 
two  log10  units  appeared  (Musser  et  al.,  1960). 
Nevertheless,  this  is  the  only  report  about  a  higher 
stability at a higher temperature for measles virus. This is 
in contrast to the data presented in this study.  
Interestingly, a higher inactivation rate was reported 
at 6°C, when MV particles were prepared in serum free 
medium.  At  this  temperature,  MV  titers  decreased  to 
10% of original titers in serum free preparations within 4 
weeks, while in serum containing medium the virus titer 
was  more  or  less  stable  (5  +/-0.3  log10  TCID50  mL
-1) 
(Musser  et  al.,  1960).  In  water-suspensions,  MV 
preparations lost 90% of infectivity within 24 h at 4°C 
and 50% within 1 h at 25°C (Rapp et al., 1965). This 
shows  that  measles  virus  particles  in  suspension  need 
certain  supplements  to  retain  their  infectivity.  While 
serum  was  reported  to  be  very  effective,  other 
supplements  like  sugar,  amino  acids  and  divalent  ions 
were  already  reported  to  preserve  measles  virus 
infectivity (Trabelsi et al., 2012). Weiss, K. et al. / American Journal of Biochemistry and Biotechnology 9 (3): 243-254, 2013 
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The thermal inactivation reactions follow first order 
kinetics for all analyzed temperatures (Fig. 1), which is 
also reported for tobacco mosaic virus (Ginoza, 1958), 
Sindbis  virus  (Barnes  et  al.,  1969)  and  baculovirus 
(Gotoh et al., 2008). The corresponding Arrhenius plot 
(Fig.  2)  indicates  only  one  process  parameter  that 
contributes  to  MV  inactivation  due  to  temperature 
sensitivity in our experimental setting. A two component 
mode  mechanism  of  inactivation  in  which  inactivation 
proceeds in the first place in a faster manner and then a 
slower degradation is observed that  follows  first order 
kinetics  had  been  reported  for  lyophilized  measles 
vaccine (Allison et al., 1981; Colinet et al., 1982). For 
unprocessed MV at 45°C and 50°C this so called two 
component mode has also been shown for the Schwarz 
and Mantooth strain (Albrecht and Schumacher, 1972) 
and at 4°C for the AIK-C strain (Trabelsi et al., 2012). 
For  the  Edmonston  MV  strain  a  two  component 
inactivation  was suggested only by the data at45°C or 
50°C (Rapp et al., 1965).  
In a previous study (Woese, 1960), an enthalpy of 20 
kcal mol
-1 and an entropy of -19 cal mol
-1 °C
-1 had been 
determined  for  Tobacco  Mosaic  Virus  (TMV)  RNA 
which  was  designated  to  be  associated  with  RNA 
inactivation.  In  general  RNA  inactivation  was 
accompanied  by  a  small  value  for  enthalpy  and  a 
negative value for entropy. In the same study, positive 
entropy  values  between  3  to  950  cal  mol
-1  °C
-1  of 
thermal inactivation were reported for proteins, bacterial 
and  plant  viruses  and  other  animal  viruses  (Woese, 
1960).  The  thermodynamic  parameters  for  MV 
inactivation as determined in this study are summarized 
in  Table  1.  The  enthalpy  and  entropy  for  thermal 
inactivation  of  MV  were  25  kcal  mol
-1  and  20  cal 
mol
-1 K
-1, respectively. According to Woese (1960), the 
values  in  this  study  could  suggest  that  measles  virus 
inactivation  is  accompanied  by  both  RNA  and  protein 
inactivation.  For  the  enthalpy  of  measles  virus  heat 
inactivation values of 18 to 70 kcal mol
-1 (23°C to 56°C) 
were  reported  in  the  literature  (Woese,  1960).  As  the 
enthalpy  is  greater  than  zero  the  reaction  is  so  called 
endothermic,  which  means  that  for  measles  virus 
inactivation  energy  must  be  absorbed  into  the  system. 
According  to  the  second  law  of  thermodynamic,  an 
entropy  larger  than  zero  indicates  an  irreversible 
reaction,  meaning  that  in  this  study  MV  thermal 
inactivation is estimated to be a non-reversible process. 
Measles  virus  thermal  inactivation  as  a  reversible 
process,  according  to  entropy  of  zero,  has  never  been 
reported and such back formation without any permanent 
alteration of the system or its surrounding is not expected 
for a biological system.  
Similar to Murine Leukemia Virus (MLV) production, 
the high degradation rate at 37°C (Nehring et al., 2006) 
presents a new challenge for the production process. To 
achieve  the  high  amounts  of  infectious  virus  particels 
virus filtration for concentration is a possible solution, like 
it  has  been  reported  for  MLV,  (Nehring  et  al.,  2004; 
2009),  densonucleosis  virus  (Czermak  et  al.,  2008; 
Grzenia et al., 2006; Specht et al., 2004), recombinant 
baculovirus (Grein et al., 2012; Michalsky et al., 2009; 
2010)  and  minute  virus  (Hensgen  et  al.,  2010).  MV 
purification in a scale of up to 60 L is already reported 
by Langfield et al. (2011), but especially the half-life of 
2 and 1 h of MV particles at 32 and 37°C, respectively, 
suggests  inline  filtration  with  continues  harvest  and 
immediate cooling like it has already been reported for 
MLV particles (Nehring et al., 2009). 
Referring to pH stability, the data in this report (Fig. 
3)  reveal  that  MV  is  very  sensitive  towards  changes 
away  from  neutral  (pH  7.2).  This  shows  that  process 
conditions  have  to  be  adjusted  during  upstream  and 
downstream processing. Inactivation of MV due to pH 
sensitivity has already been presented, before. Similar to 
the results presented here, a total virus inactivation at pH 
>10  or  <  5  has  been  reported  (Musser  et  al.,  1960). 
Stable virus titers were identified between pH 7 and 8, 
whereas between pH 5 and 7 or 8 and 9 inactivation was 
between one to two log10 units (Musser et al., 1960). 
Black reported a maximum virus titer of 7.9×10
3 pfu at 
pH  7.6,  a  stable  titer  from  pH  6  to  10.5  (maximum 
decrease  of  0.6  log10  units),  but  a  comparably  high 
inactivation  at  pH  4.4,  3.8  and  2.4  of  2.8  log10  units, 
representing  a  loss  of  80%  (Black,  1959).  Such 
sensitivity  towards  pH  changes  was  also  reported  for 
recombinant  baculovirus.  In  this  case  particles 
aggregation due to pH changes has been suggested to 
be  responsible  for  the  observed  virus  inactivation 
(Grein  et  al.,  2012).  The  data  show  that  for  an 
optimized production process pH regulation in narrow 
limits  during  upstream  and  downstream  processing  is 
essential to preserve measles virus infectivity. 
As  depicted  in  Table  2,  MV  titers  did  not 
significantly  decrease  with  either  a  rising  or  falling 
conductivity.  This  stability  of  MV  under  different  salt 
concentrations indicates that the sensitivity of MV to pH 
differing  from  neutral  was  not  due  to  enhanced  ion 
concentrations, but linked to proton concentration. The 
ions Ca
2+, Zn
2+ and Mg
2+ can be associated to different 
proteins and especially MgSO4 was reported to improve 
MV stability or even production yield (Boriskin et al., Weiss, K. et al. / American Journal of Biochemistry and Biotechnology 9 (3): 243-254, 2013 
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1988; Rapp et al., 1965; Trabelsi et al., 2012). While 
a negative impact of MgSO4 on measles virus could 
not  be  observed  in  the  present  study,  it  possibly 
improves the virus yield during production. 
To date, no analysis concerning the sensitivity of MV 
towards  oxygen  has  been  published.  However,  this 
parameter is essential in bioprocess evaluation and scale 
up investigations as it is necessary for the growth of the 
mammalian  host  cells.  Especially  in  scale  up 
investigations  dealing  with  high  cell  concentrations 
aeration and the oxygen partial pressure is an important 
factor.  The  negative  effect  of  oxygen  is  given  by  the 
formation  of  oxygen  radicals  in  redox  reactions  by 
several enzymes. Oxygen radicals are highly reactive and 
contingently destructive to biomolecules or its functional 
groups.  Therefore,  high  oxygen  concentrations 
potentially resulting in generation of larger amounts of 
oxygen  radicals  may  be  counterproductive  for  virus 
stability  due  to  biochemical  redox  reactions  e.g.,  with 
subsequent inactivation of viral surface proteins critical 
for infectivity (Lim et al., 1999). For these reasons it was 
analyzed, whether oxygen is a critical parameter for MV 
stability. For an exemplary test, small scale laboratory 
conditions were chosen, where measles virus production 
is currently evaluated (manuscript in preparation). Under 
these  conditions  MV  titers  were  stable  at  an  oxygen 
partial  pressure  of  100%,  indicating  resistance  of  MV 
particles  against  inactivation  under  high  oxygen 
concentrations. The result presented shows that in scale 
up  investigations  a  high  oxygen  demand  of  Vero  cell 
cultures after infection is no critical factor after infection, 
whereby this enables working at high cell concentrations. 
In  summary,  this  study  shows  which  parameters 
should  be  considered  for  further  production 
evaluation.  Identified  critical  parameters  could  be 
controlled  strongly  in  the  production  process  to 
further raise measles virus yields for the high amount 
needed  in  cancer  therapy  approaches.  High  thermal 
inactivation should be considered when thinking about 
time  of  harvest  or  continuous  cooling  during 
downstream processing. A half-life of 1 and 2h at 37 
and 32°C, respectively, shows that harvest of measles 
virus  particles  should  be  performed  several  fold  or 
even  continuously.  After  that  immediate  cooling  of 
the  virus  suspension  is  essential  to  retain  the 
infectivity. pH sensitivity is also an important factor 
when thinking about automatic pH regulation during 
measles virus production. Interestingly, measles virus 
showed  no  sensitivity  towards  an  oxygen  partial 
pressure  of  100%  or  varying  conductivities  between 
1.4 and 138 mS cm
-1. Measles virus stability towards 
different salt concentrations could be an advantage in 
purification approaches using ion exchange membrane 
chromatography.  This  purification  has  already  been 
reported  for  recombinant  baculovirus  (Grein  et  al., 
2012) and densonucleosis virus (Specht et al., 2004). 
5. CONCLUSION 
The  results  presented  show  how  process 
parameters could affect final infectious MV yields at 
production and purification. 
Aiming for high amounts of infectious MV particles 
for  the  applications  in  cancer  therapy,  future  studies 
should  go  in  more  detailed  investigations  for  MV 
stability  and  should  also  integrate  them  into  the 
evaluation of MV production. 
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